ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HIV virus"

  • 2021 American Transplant Congress

    Posttransplant Malignancy in HIV+ Kidney Transplant Recipients

    D. Sawinski1, R. Fitzsimmons1, J. Locke2, J. Trofe-Clark1, B. Shelton2, P. Reese1, E. Blumberg1

    1Hospital of the University of Pennsylvania, Philadelphia, PA, 2University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Kidney transplant recipients and people living with HIV are both at increased risk for malignancy, including cancers that are virally-mediated. Despite the recognition of…
  • 2021 American Transplant Congress

    Covid-19 in Hiv-infected Solid Organ Transplant Recipients: A Case Series

    M. Ramanathan, A. Fernandez, Y. Natori, J. Simkins, J. Camargo, M. Morris, N. Rivera, M. Loebe, G. Ciancio, L. Abbo, A. Mattiazzi, G. Guerra, S. Anjan

    University of Miami, Miami, FL

    *Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased mortality and morbidity in immunosuppressed patients. Data on management and outcomes in HIV-infected solid organ transplant…
  • 2021 American Transplant Congress

    Kidney Transplant Outcomes in HIV+ Recipients: A Single-Center Study

    M. Samra1, A. Hall2, I. Tang2

    1Medicine, Edward Hines VA, Hines, IL, 2Medicine, University of Illinois, Chicago, IL

    *Purpose: HIV+ patients are eligible to recieve a kidney transplant (KT) provided they meet criteria of undetectable viral load (VL) and CD4 count >200. We…
  • 2021 American Transplant Congress

    Efficacy of Hope: Analysis of Quality HIV+ Deceased Donor Organ Availability

    G. E. Owens1, B. Shelton1, P. MacLennan1, D. Sawinski2, J. E. Locke1

    1Transplant, University of Alabama at Birmingham, Birmingham, AL, 2Transplant, University of Pennsylvania, Philadeplphia, PA

    *Purpose: The purpose of this study is to understand the number of organs actually available for HIV+ to HIV+ transplant utilizing data on a national…
  • 2020 American Transplant Congress

    The Forgiven Disease: Outcomes of Lung Transplantation in Two HIV-Infected Patients

    S. Biswas Roy1, M. T. Olson2, M. A. Smith1, R. M. Bremner1, R. Walia1, A. Arjuna1

    1Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, 2University of Arizona College of Medicine - Phoenix, Phoenix, AZ

    *Purpose: Human immunodeficiency virus (HIV) seropositivity is generally considered a contraindication to lung transplantation (LTx). HIV-infected adults are at higher risk of developing chronic lung…
  • 2020 American Transplant Congress

    Conversion to Belatacept in HIV(+) Renal Transplant Recipients

    A. Santeusanio, A. Bhansali, R. Shapiro, G. De Boccardo

    Mount Sinai Hospital, New York, NY

    *Purpose: HIV(+) renal transplant recipients were excluded from phase III trials of belatacept, and currently there are only scattered case reports.*Methods: This was a single…
  • 2020 American Transplant Congress

    HIV+ Living Kidney Donors in the United States: Cases and a Clinical Paradigm

    D. Segev1, C. Wolfe2, D. Brown3, D. Fine3, K. Neumann4, N. Martinez5, D. Ostrander3, F. Al Ammary3, A. Tobian3, A. W. Baker6, C. Durand3

    1Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, 2Duke University Medical Center, Durham, NC, 3Johns Hopkins University, School of Medicine, Baltimore, MD, 4Unaffiliated, N/A, VA, 5Unaffiliated, N/A, GA, 6Duke University, School of Medicine, Durham, NC

    *Purpose: To report clinical characteristics and outcomes of two people living with HIV who underwent laparoscopic donor nephrectomy*Methods: To facilitate donor selection, we first conducted…
  • 2020 American Transplant Congress

    Willingness to Accept and Beliefs Regarding Organs from HIV-Infected Donors: A Multi-Center Survey of Transplant Candidates Living with HIV

    S. Rasmussen1, S. Seaman1, M. Bowring1, D. Brown1, A. Massie1, A. Tobian1, M. Henderson1, F. Fletcher2, B. Smith2, A. Chao3, N. Gorupati3, K. Prakash4, S. Aslam4, D. Lee5, S. Trinh6, V. Kirchner7, T. Pruett7, G. Haidar8, K. Hughes8, M. Malinis9, D. Segev1, J. Sugarman1, C. Durand1

    1JHU, Baltimore, MD, 2UAB, Birmingham, AL, 3UCSF, San Francisco, CA, 4UCSD, San Diego, CA, 5Drexel, Philadelphia, PA, 6Ochsner, New Orleans, LA, 7UMN, Minneapolis, MN, 8UPMC, Pittsburgh, PA, 9Yale, New Haven, CT

    *Purpose: HIV-infected (HIV+) donor to HIV+ recipient (HIV D+/R+) transplantation might improve access to transplantation for candidates living with HIV. However, it is unclear whether…
  • 2020 American Transplant Congress

    Outcomes of Hiv-Positive Patients Post-Cardiac Transplantation

    G. S. Liu1, A. M. Wolfson2, A. D. Salimbangon3, R. R. Chand4, P. Banankhah1, J. Nattiv1, P. A. Genyk1, P. A. Kingsford1, J. P. Li1, D. Vucicevic5, K. Pandya1, J. Rahman1, M. Fong1, E. C. DePasquale1, A. S. Vaidya1

    1Keck Medicine of USC, Los Angeles, CA, 2University of Arizona Sarver Heart Center, Tucson, AZ, 3UCLA Medical Center, Los Angeles, CA, 4Harbor-UCLA Medical Center, Los Angeles, CA, 5Newark Beth-Israel Medical Center, Newark, NJ

    *Purpose: Human immunodeficiency virus (HIV) infection is no longer an absolute contraindication to heart transplantation (HT) in many HT centers, but long-term post-HT outcomes of…
  • 2020 American Transplant Congress

    Improved Outcomes Over the Past 13 Years in HIV Positive Kidney Transplant Recipients-A Single Center Experience

    A. Mattiazzi1, J. F. Camargo2, S. Anjan2, M. I. Morris2, L. Abbo2, J. Simkins2, Y. Natori2, K. Aoke3, A. Zilli3, R. Thurston3, M. Muldoon3, L. Preczewski3, L. J. Chen4, G. W. Burke4, G. Ciancio4, G. Guerra1

    1Medicine. Division of Nephrology, University of Miami/Miami Transplant Institute, Miami, FL, 2Medine. Division of Infectious Disease, University of Miami/Miami Transplant Institute, Miami, FL, 3Miami Transplant Institute, Miami, FL, 4Surgery, University of Miami/Miami Transplant Institute, Miami, FL

    *Purpose: Kidney transplantation in HIV positive recipients (HIV+) is the treatment of choice for renal failure in patients (P) who maintain CD4+ counts ≥ 200/mm3and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences